Search Results - "G, Saydam"

Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B‐cell lymphoma (PMBCL) by McDonald, A., Verburgh, E., Gotti, M., Pinto, A., Zaucha, J., Ivanov, V., Melnichenko, V., Mocikova, H., Ozcan, M., Patti, C., Farias, J., Goncalves, I., Kuchkova, O., Mayer, J., Saydam, G., Tomassetti, S., Pathiraja, K., Ryland, K., Chakraborty, S., Jurczak, W.

Get full text

3207 Down-regulated RNF5 (RING finger domain E3 ligase) ubiquitinproteasome pathway related gene expression by resveratrol leads to inhibition of cell proliferation and motility in chronic myeloid leukemia cells by Avci, C. Biray, Mutlu, Z, Goker, B, Caliskan, C, Ozalp, O, Saydam, G, Gunduz, C

Get full text

PP-070 HEMOGLOBIN O ARAB IN AN ASYMPTOMATIC PATIENT by Duran, M, Comert, M, Saydam, G

Get full text

CHRONOS‐3: RANDOMIZED PHASE III STUDY OF COPANLISIB PLUS RITUXIMAB VS RITUXIMAB/PLACEBO IN RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (INHL) by Zinzani, P. L., Capra, M., Özcan, M., Lv, F., Li, W., Yañez, E., Sapunarova, K., Lin, T., Jin, J., Jurczak, W., Hamed, A., Wang, M.‐C., Baker, R., Bondarenko, I., Zhang, Q., Feng, J., Geissler, K., Lazaroiu, M., Saydam, G., Szomor, Á., Bouabdallah, K., Galiulin, R., Uchida, T., Mongay Soler, L., Cao, A., Hiemeyer, F., Mehra, A., Childs, B. H., Shi, Y., Matasar, M. J.

Get full text

PP-064 A METHOTREXATE RELATED CASE WITH LYMPHADENOPATHIES by Uysal, A. Oruc, Ozkan, M. Comert, Ozsan, N, Saydam, G, Sahin, F

Get full text

PP-053 OSTEOSCLEROSIS IN SYSTEMIC MASTOCYTOSIS by Alp, G, Ozkan, M. Comert, Hekimgil, M, Sahin, F, Saydam, G

Get full text

PP-050 DIFFUSE LARGE B-CELL LYMPHOMA IN β-THALASSEMIA MAJOR by Patir, P, Kiper, H, Kir, O, Soyer, N, Saydam, G

Get full text

PP-114 RELAPSE/REFRACTORY MYELOMA AND CARFILZOMIB by Uysal, A, Comert, M, Sahin, F, Tombuloglu, M, Saydam, G

Get full text

PP-119 RADIOISOTOPE SYNOVECTOMY RESULTS IN EGE ADULT HEMOPHILIA CENTER (2001–2011): 11 YEARS EXPERIENCE by Patir, P, Soyer, N, Comert, M, Saydam, G, Sahin, F

Get full text

Real experience of brentuximab vedotin for cutaneous T cell lymphomas by F. Keklik Karadag, A. Arslan, T. Pashayev, N. Akad Soyer, F. Sahin, F. Vural, M. TöBü, G. Saydam

Get full text

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS‐3 TRIAL by Zinzani, P. L., Özcan, M., Sapunarova, K., Jurczak, W., Hamed, A., Bouabdallah, K., Saydam, G., Geissler, K., Szomor, Á., Lazaroiu, M., Salar, A., Tempescul, A., Nalcaci, M., Gercheva, L., Egyed, M., Panayiotidis, P., Mongay Soler, L., Cao, A., Phelps, C., H Childs, B., J Matasar, M.

Get full text

PP-061 TET2, ASXL1, IDH1 AND IDH2 MUTATIONS IN NON-CML MYELOPROLIFERATIVE NEOPLASMS by Soyer, N. Akad, Kaymaz, B. Tezcanli, Ozkan, M. Comert, Aktan, C, Sahin, F, Kosova, B, Saydam, G

Get full text

PP-121 IS THERE A CORRELATION BETWEEN SERUM GALACTOMANNAN POSITIVITY AND HRCT FINDINGS IN HEMATOPOIETIC STEM CELL RECIPIENTS? by Ozkan, M. Comert, Uysal, A. Oruc, Soyer, N. Akad, Arda, B, Sahin, F, Saydam, G, Vural, F

Get full text

PP-115 ATYPICALLY LOCALIZED HODGKIN’S LYMPHOMA by Uysal, A, Comert, M, Ozsan, N, Omur, O, Saydam, G, Sahin, F

Get full text

PP-026 INVESTIGATING THE ROLE OF JAK/STAT PATHWAY UPON DASATINIB INDUCE DAPOPTOSIS FOR CML CELL MODEL K562 by Dalgic, C. Tunakan, Kaymaz, B.T, Dalmizrak, A, Comert, M, Kosova, B, Sahin, F, Saydam, G

Get full text

PP-027 AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION IN SOLID TUMORS:SINGLE INSTITUTION EXPERIENCE by Soyer, N, Yilmaz, A, Uslu, R, Gorcegiz, A, Saydam, G, Sahin, F, Vural, F

Get full text

PP-116 EVALUATION OF FEBRILE NEUTROPENIC EPISODES IN HEMATOPOIETIC STEM CELL TRANSPLANTATIONS by Ozkan, M. Comert, Uysal, A. Oruc, Soyer, N. Akad, Arda, B, Sahin, F, Saydam, G, Vural, F

Get full text

PP-019 OCULAR ADNEXAL LYMPHOMAS: SINGLE CENTER EXPERIENCE by Ozkan, M. Comert, Onay, M. Palamar, Tombuloglu, M, Hekimgil, M, Ozsan, N, Saydam, G, Sahin, F

Get full text

PP-051 NILOTINIB INDUCES APOPTOSIS THROUGH JAK/STAT PATHWAY MEMBERS STAT5A & STAT5B IN K562 CML CELL MODEL by Yavuz, T. Guliyeva, Kaymaz, B. Tezcanlı, Özkan, M. Comert, Kosova, B, Sahin, F, Saydam, G

Get full text

PP-091 INVESTIGATING THE POTENTIAL EFFECTS OF SUNITINIB IN K-562 CHRONIC MYELOGENOUS LEUKEMIA CELL LINE AND ASSESSMENT OF GENE PROFILING by Ozkan, M. Comert, Kaymaz, B. Tezcanli, Aktan, C, Sahin, F, Kosova, B, Dalkilic, A, Saydam, G

Get full text